OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
Clinical trial NCT07221799 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07221799
- Sponsor
- University of Maryland, Baltimore
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.